RecruitingNot ApplicableNCT07427108
Road Mapping Guided Puncture Versus Ultrasound Guided Puncture During Retrograde Angioplasty Feasibility and Safety
Sponsor
Sohag University
Enrollment
32 participants
Start Date
Feb 1, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
The study aims to compare the technical feasibility and safety of road mapping-guided versus ultrasound-guided retrograde arterial puncture in patients with (CLTI) as measured by: * Puncture success rate * Access-related complication rate (e.g., hematoma, vessel dissection, perforation)
Eligibility
Min Age: 18 Years
Inclusion Criteria7
- Adults : Both male and female participants.
- Diagnosed with critical limp threatening ischemia (CLTI):
- significant occlusions in the femoropopliteal
- o Rutherford Class 5: Non-healing wounds or ulcers
- Failed or unable to achieve antegrade access:
- Patients requiring retrograde puncture for the procedure.
- Planned intervention with retrograde access: Candidates for endovascular interventions, including angioplasty, stent deployment
Exclusion Criteria2
- Active infection at the puncture site: Any localized infection, particularly over the ankle region , will be an exclusion.
- Severe calcification or anatomical abnormalities: Patients with excessive arterial calcification or significant anatomical distortion preventing safe retrograde puncture.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDURERoad-map guided versus US guided retrograde access
Road-map guided versus US guided retrograde access
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07427108
Related Trials
Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke
NCT066159731 location
Natural History of Stroke: Cause and Development
NCT000092433 locations
Hypertension Explored in Long-term Postpartum Follow-up in Later Life
NCT061870121 location
Handgrip Training in Patients With Peripheral Artery Disease
NCT036637772 locations
SELUTION4BTK Trial
NCT0505529748 locations